68 related articles for article (PubMed ID: 1683921)
1. p53 germline mutations in Li-Fraumeni syndrome.
Santibáñez-Koref MF; Birch JM; Hartley AL; Jones PH; Craft AW; Eden T; Crowther D; Kelsey AM; Harris M
Lancet; 1991 Dec; 338(8781):1490-1. PubMed ID: 1683921
[TBL] [Abstract][Full Text] [Related]
2. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations.
Liu PK; Kraus E; Wu TA; Strong LC; Tainsky MA
Oncogene; 1996 Jun; 12(11):2267-78. PubMed ID: 8649766
[TBL] [Abstract][Full Text] [Related]
3. Waiting and "weighted down": the challenge of anticipatory loss for individuals and families with Li-Fraumeni Syndrome.
Werner-Lin A; Young JL; Wilsnack C; Merrill SL; Groner V; Greene MH; Khincha PP
Fam Cancer; 2020 Jul; 19(3):259-268. PubMed ID: 32222840
[TBL] [Abstract][Full Text] [Related]
4. Absence of germline CHK2 mutations in familial gastric cancer.
Kimura K; Shinmura K; Yoshimura K; Shimizu K; Katai H; Beppu Y; Moriya H; Yokota J
Jpn J Cancer Res; 2000 Sep; 91(9):875-9. PubMed ID: 11011113
[TBL] [Abstract][Full Text] [Related]
5. Cascade screening in HBOC and Lynch syndrome: guidelines and procedures in a UK centre.
Evans DG; Green K; Burghel GJ; Forde C; Lalloo F; Schlecht H; Woodward ER
Fam Cancer; 2024 Jun; 23(2):187-195. PubMed ID: 38478259
[TBL] [Abstract][Full Text] [Related]
6. Breast cancer genomes from CHEK2 c.1100delC mutation carriers lack somatic TP53 mutations and display a unique structural variant size distribution profile.
Smid M; Schmidt MK; Prager-van der Smissen WJC; Ruigrok-Ritstier K; Schreurs MAC; Cornelissen S; Garcia AM; Broeks A; Timmermans AM; Trapman-Jansen AMAC; Collée JM; Adank MA; Hooning MJ; Martens JWM; Hollestelle A
Breast Cancer Res; 2023 May; 25(1):53. PubMed ID: 37161532
[TBL] [Abstract][Full Text] [Related]
7. Targeting Nuclear NAD
Kiss A; Ráduly AP; Regdon Z; Polgár Z; Tarapcsák S; Sturniolo I; El-Hamoly T; Virág L; Hegedűs C
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32392755
[TBL] [Abstract][Full Text] [Related]
8. Oxidized DJ-1 inhibits p53 by sequestering p53 from promoters in a DNA-binding affinity-dependent manner.
Kato I; Maita H; Takahashi-Niki K; Saito Y; Noguchi N; Iguchi-Ariga SM; Ariga H
Mol Cell Biol; 2013 Jan; 33(2):340-59. PubMed ID: 23149933
[TBL] [Abstract][Full Text] [Related]
9. Chromosome instability and deregulated proliferation: an unavoidable duo.
Coschi CH; Dick FA
Cell Mol Life Sci; 2012 Jun; 69(12):2009-24. PubMed ID: 22223110
[TBL] [Abstract][Full Text] [Related]
10. A unique occurrence of a cerebral atypical teratoid/rhabdoid tumor in an infant and a spinal canal primitive neuroectodermal tumor in her father.
Izycka-Swieszewska E; Debiec-Rychter M; Wasag B; Wozniak A; Gasecki D; Plata-Nazar K; Bartkowiak J; Lasota J; Limon J
J Neurooncol; 2003 Feb; 61(3):219-25. PubMed ID: 12675315
[TBL] [Abstract][Full Text] [Related]
11. Simultaneous adrenocortical carcinoma and ganglioneuroblastoma in a child with Turner syndrome and germline p53 mutation.
Pivnick EK; Furman WL; Velagaleti GV; Jenkins JJ; Chase NA; Ribeiro RC
J Med Genet; 1998 Apr; 35(4):328-32. PubMed ID: 9598730
[TBL] [Abstract][Full Text] [Related]
12. Analysis of p53 gene deletions in colorectal cancers using fluorescence in situ hybridization.
Nanashima A; Tagawa Y; Yasutake T; Taniguchi Y; Sawai T; Nakagoe T; Ayabe H
Surg Today; 1997; 27(11):999-1004. PubMed ID: 9413050
[TBL] [Abstract][Full Text] [Related]
13. Li-Fraumeni syndrome--a molecular and clinical review.
Varley JM; Evans DG; Birch JM
Br J Cancer; 1997; 76(1):1-14. PubMed ID: 9218725
[No Abstract] [Full Text] [Related]
14. Tumors associated with p53 germline mutations: a synopsis of 91 families.
Kleihues P; Schäuble B; zur Hausen A; Estève J; Ohgaki H
Am J Pathol; 1997 Jan; 150(1):1-13. PubMed ID: 9006316
[TBL] [Abstract][Full Text] [Related]
15. An extended Li-Fraumeni kindred with gastric carcinoma and a codon 175 mutation in TP53.
Varley JM; McGown G; Thorncroft M; Tricker KJ; Teare MD; Santibanez-Koref MF; Martin J; Birch JM; Evans DG
J Med Genet; 1995 Dec; 32(12):942-5. PubMed ID: 8825920
[TBL] [Abstract][Full Text] [Related]
16. No defect in G1/S cell cycle arrest in irradiated Li-Fraumeni lymphoblastoid cell lines.
Williams KJ; Heighway J; Birch JM; Norton JD; Scott D
Br J Cancer; 1996 Sep; 74(5):698-703. PubMed ID: 8795570
[TBL] [Abstract][Full Text] [Related]
17. The MDM2 oncoprotein is overexpressed in rhabdomyosarcoma cell lines and stabilizes wild-type p53 protein.
Keleti J; Quezado MM; Abaza MM; Raffeld M; Tsokos M
Am J Pathol; 1996 Jul; 149(1):143-51. PubMed ID: 8686737
[TBL] [Abstract][Full Text] [Related]
18. Tumourigenesis associated with the p53 tumour suppressor gene.
Chang F; Syrjänen S; Tervahauta A; Syrjänen K
Br J Cancer; 1993 Oct; 68(4):653-61. PubMed ID: 8398688
[TBL] [Abstract][Full Text] [Related]
19. Molecular alterations in a patient with Turcot's syndrome.
Rochlitz CF; Heide I; de Kant E; Neubauer A; Schmidt CA; Neuhaus P; Huhn D; Herrmann R
Br J Cancer; 1993 Sep; 68(3):519-23. PubMed ID: 8394730
[TBL] [Abstract][Full Text] [Related]
20. Familial breast cancer.
Evans DG; Fentiman IS; McPherson K; Asbury D; Ponder BA; Howell A
BMJ; 1994 Jan; 308(6922):183-7. PubMed ID: 8312772
[No Abstract] [Full Text] [Related]
[Next] [New Search]
